Go Back

SNM/EANM Procedure Guidelines for Infection/Inflammation


  • The purpose of these Society of Nuclear Medicine (SNM) and European Association of Nuclear Medicine (EANM) Procedure - Guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of common studies for infection and inflammation indications.

  • SNM Procedure Guideline for Gallium Scintigraphy in Inflammation (2004)

    67Ga scintigraphy may include regional, whole-body, planar, and SPECT scintigrams, or any combination performed after intravenous injection of 67Ga-citrate.

  • SNM Procedure Guideline Tc-99m HMPAO-Labeled Leukocyte Scintigraphy (2004)

    The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of 99mTc-Exametazime (HMPAO)-Labeled Leukocyte Scintigraphy . 99mTc-leukocyte scintigraphy consists of regional, whole-body, planar, and SPECT scintigrams obtained after intravenous injection of 99mTc-labeled leukocytes for suspected infection/inflammation.

  • SNM Procedure Guideline In-111 Leukocyte Scintigraphy (2004)

    111In-leukocyte scintigraphy is a diagnostic imaging test that displays the distribution of radiolabeled leukocytes in the body. Regional, whole-body, planar, and/or SPECT scintigrams of specific anatomic regions are obtained for suspected infection/inflammation.

  • EANM Guidelines for the labelling of leucocytes with In-111-oxine (2010)

    A protocol is described for labelling autologous white blood cells with 111In-oxine based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.

  • EANM Guidelines for the labelling of leucocytes with Tc-99m-HMPAO (2010)

    A protocol is described for labelling autologous white blood cells with 99mTc-HMPAO based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.